Phenominer Database Results (18 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
ACI/SegHsd prostate tumorous lesion number control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 12 5.3 null ex vivo light microscopy 0 0 65822 341
F344/Jcl percentage of study population developing ventral prostate tumorous lesions during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 50.0 % ex vivo light microscopy 0 0 65824 341
F344/Jcl percentage of study population developing leukemia during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. leukocyte integrity trait male 900 days 8 25.0 % ex vivo light microscopy 0 0 leukemia incidence 66142 341
ACI/SegHsd percentage of study population developing bilateral testis tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis integrity trait male 900 days 12 25.0 % ex vivo light microscopy 0.0 0 necropsy bilateral testis tumor incidence 67948 341
ACI/SegHsd percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 12 92.0 % ex vivo light microscopy 0.0 0 109885 341
F344/Jcl percentage of study population developing testis tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis integrity trait male 900 days 8 100.0 % ex vivo light microscopy 0.0 0 testis tumor incidence 65841 341
F344/Jcl number of ventral prostate tumorous lesions with solid structure control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 0.4 null 0.25 0.7 ex vivo light microscopy 0.0 0 109888 341
ACI/SegHsd percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 12 100.0 % ex vivo light microscopy 0.0 0 109957 341
ACI/SegHsd percentage of study population developing ventral prostate tumorous lesions during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 12 100.0 % ex vivo light microscopy 0 0 65825 341
ACI/SegHsd percentage of study population developing testis tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis integrity trait male 900 days 12 92.0 % ex vivo light microscopy 0.0 0 testis tumor incidence 65840 341
F344/Jcl percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 25.0 % ex vivo light microscopy 0.0 0 109886 341
ACI/SegHsd number of ventral prostate tumorous lesions with solid structure control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 12 3.0 null 0.75 2.6 ex vivo light microscopy 0.0 0 109887 341
ACI/SegHsd number of ventral prostate tumorous lesions with round, irregular size nuclei control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 12 5.1 null 0.69 2.4 ex vivo light microscopy 0.0 0 109959 341
ACI/SegHsd percentage of study population developing leukemia during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. leukocyte integrity trait male 900 days 12 0.0 % ex vivo light microscopy 0 0 leukemia incidence 66143 341
F344/Jcl percentage of study population developing bilateral testis tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. testis integrity trait male 900 days 8 88.0 % ex vivo light microscopy 0.0 0 necropsy bilateral testis tumor incidence 67949 341
F344/Jcl percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 38.0 % ex vivo light microscopy 0.0 0 109958 341
F344/Jcl number of ventral prostate tumorous lesions with round, irregular size nuclei control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 1.3 null 0.64 1.8 ex vivo light microscopy 0.0 0 109960 341
F344/Jcl prostate tumorous lesion number control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. prostate integrity trait male 900 days 8 1.5 null ex vivo light microscopy 0 0 65823 341